About Rhein Biotech
Rhein Biotech is a Healthcare company based in Dusseldorf (Germany) founded in 1993, and was acquired by Dynavax in April 2006. Therapeutic solutions for infectious and inflammatory diseases are developed. Its chief executive, as recorded, is Zbigniew Janowicz. The company was acqui-hired. Its focus areas include Life Sciences, Immunotherapy, Antibody and Immunomodulatory.
Company details
Founded in 1993 in Dusseldorf, Germany, the company operates in the biotechnology sector. Therapeutic solutions are developed for infectious and inflammatory diseases, including the HEPLISAV candidate for hepatitis B treatment. Vaccines and immune modulators are provided for conditions such as diphtheria, encephalitis, typhoid, tetanus, hemorrhagic fever, and influenza. Operations focus on research and development of these products.
- Headquarters Dusseldorf, Germany
- Stage Acquired
- SectorsHealthcare
- Website rheinbiotech.com
- Acquired by Dynavax (Apr 2006)
- Investors
- Acquired byDynavax
(Apr 2006)
Investors in Rhein Biotech
Rhein Biotech has secured backing from 1 investor. Prominent investors backing the company include Dynavax Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A biopharmaceutical company focused on developing novel vaccines. | 1996 | dynavax.com | Berkeley, United States |
Investor details for Rhein Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Rhein Biotech
1 people are tracked at Rhein Biotech (1 in leadership).
| Name | Role | Group |
|---|---|---|
Zbigniew Janowicz | CEO | Leadership |
Complete people profiles for Rhein Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Rhein Biotech
2 dated milestones of Rhein Biotech across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Rhein Biotech is founded.
- Exit Acquired by Dynavax.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rhein Biotech
Rhein Biotech was founded in 1993.
Rhein Biotech is headquartered in Dusseldorf, Germany. It is registered at Dusseldorf, North Rhine-westphalia, Germany.
Zbigniew Janowicz is the CEO of Rhein Biotech, as recorded in our data.
Founded in 1993 in Dusseldorf, Germany, the company operates in the biotechnology sector. Therapeutic solutions are developed for infectious and inflammatory diseases, including the HEPLISAV candidate for hepatitis B treatment. Vaccines and immune modulators are provided for conditions such as diphtheria, encephalitis, typhoid, tetanus, hemorrhagic fever, and influenza. Operations focus on research and development of these products.
Rhein Biotech has 1 investor. Key investors include Dynavax Technologies.
Yes. Rhein Biotech was acquired by Dynavax in April 2006.